PPT - Kawasaki Disease: An Update of diagnosis and treatment PowerPoint Presentation - ID:597931
Table 3 from Is High-Dose Aspirin Necessary in the Acute Phase of Kawasaki Disease? | Semantic Scholar
Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease - ScienceDirect
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Characteristics of the 851 Kawasaki disease patients. | Download Table
Understanding Kawasaki Disease
How is Kawasaki's disease treated?
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Kawasaki Sendromu
Table 1 from High-Dose Aspirin Is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease | Semantic Scholar
Kawasaki disease | PPT
Kawasaki Disease: Symptoms, Causes & Treatment
Characteristics of the 851 Kawasaki disease patients. | Download Table
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Kawasaki Disease - YouTube
Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan
Lightning Learning: Kawasaki Disease — EM3
Recommended clinical guideline for the management of Kawasaki disease... | Download Scientific Diagram
High-Dose Aspirin Preferred in Kawasaki disease
Treatment of Kawasaki disease | Download Table
Kawasaki Hastalığı - Doç Dr Osman Özdemir
How long to give Aspirin in Kawasaki Disease – Pediatric Practice… Pearls for your Pediatric Office Practice
The safety and effectiveness of clopidogrel versus aspirin in Kawasaki disease with mild-to-moderate liver injury | Scientific Reports
Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials - eBioMedicine
Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | Drugs & Therapy Perspectives
